Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of topical Avugane (valproic acid) in mild to moderate acne vulgaris
2007-000418-35Phase 2Completed
- Sponsor
- TopoTarget
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Avugane in acne vulgaris (4 arms), sponsored by TopoTarget. Primary endpoint: Mean change in total acne lesion count from baseline to week 12. Started Mar 2007; status: completed.
02
Drugs
Avugane
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2007-000418-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000418-35.